#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma Congenital absence of bile ducts Nephrotic syndrome Angelman's syndrome Gastrointestinal stromal tumour Liposarcoma metastatic Stiff person syndrome Spina bifida Muscular dystrophy B-cell lymphoma recurrent Interstitial lung disease Liver abscess Leber's congenital amaurosis Sickle cell anaemia Antiphospholipid syndrome More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Trials in Disease Hereditary angioedema – Diagnostics Osteosarcoma metastatic Immunodeficiency congenital – Diagnostics Antithrombin III deficiency – Diagnostics Mucopolysaccharidosis – Basic Information Nephroblastoma – Life with Disease Methylmalonic acidaemia – Basic Information Rhabdomyosarcoma recurrent – Diagnostics Mantle cell lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lysine Acetate Lenomorelin Carboplatin Aavanc80-5'Hotof Clotrimazole HSP-CAR19M Nazartinib Dexibuprofen Clascoterone Star-0215 Bi 765845 Allopurinol Taxanes Rbl007.2 Gallium (68Ga) Psma-R2 Cefaclor Cariprazine Clindamycin Basiliximab Pegaspargase More therapies…

    Learn about Your Condition

    Addison's disease Immune thrombocytopenia Anal cancer Bacterial prostatitis HIV infection Stem cell transplant Endometrial cancer metastatic Familial hypertriglyceridaemia Neuropathic arthropathy Nodal osteoarthritis Herpes virus infection Adenomatous polyposis coli Invasive breast carcinoma Peritoneal abscess Chronic fatigue syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myocardial infarction

  • Study on Colchicine for Patients with Angina Symptoms and Coronary Microvascular Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    • Acute myocardial infarction
    Investigated Drugs:
    • Adenosine
    • Colchicine
    • Regadenoson
    Denmark

  • Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Evolocumab
    France Germany Italy Poland Spain

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Methoxyflurane Compared to Morphine for Pain Relief in Patients with Acute Myocardial Infarction Before Hospital Admission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • MORPHINE
    France

  • Study of ceftriaxone and amoxicillin treatment in patients with acute coronary syndrome, non-ST-elevation myocardial infarction, or ST-elevation myocardial infarction

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    • Coronary artery disease
    • Myocardial infarction
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Ceftriaxone
    Finland

  • Study of early dapagliflozin treatment to reduce heart damage in patients with acute heart attack and reduced heart pumping function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Dapagliflozin
    Italy
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!